2:21cv14020 • July 22, 2021
Class Period Start
October 16, 2019
Class Period End
August 8, 2022
PSLRA Deadline
September 20, 2021
Case Allegations
10b5
Statutes of Repose
Oct 16, 2022
Country
United States
Court
Federal Court
Dec 18, 2025
A new complaint has been filed on behalf of certain investors in CorMedix Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Aug 19, 2025
The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.
Jun 30, 2025
The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.
Jun 6, 2024
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Apr 22, 2024
A new complaint has been filed on behalf of certain investors in CorMedix Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Mar 21, 2024
The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.
Nov 23, 2022
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Oct 10, 2022
A new complaint has been filed on behalf of certain investors in CorMedix Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Mar 28, 2022
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Mar 28, 2022
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Mar 8, 2022
Feb 21, 2022
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Jan 24, 2022
Dec 14, 2021
A new complaint has been filed on behalf of certain investors in CorMedix Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Oct 13, 2021
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Sep 13, 2021
Jul 22, 2021
A securities fraud class action complaint has been filed on behalf of certain investors in CorMedix Inc..
TOP
